Notes From the Field: Measles Outbreak — Central Ohio, 2022–2023

• 2023

  Log in to bookmark this resource.

  Log in
• Elizabeth Tiller; Nina Masters; Kelley Raines; Adria Mathis; Stephen Crooke; Rebecca Zwickl; Gavin French; Emily Alexy; Elizabeth Koch; Naomi Tucker; Elizabeth Wilson; Tiffany Krauss; Erica Leasure; Jeremy Budd; Laurie Billing; Courtney Dewart; Kara Tarter; Kristen Dickerson; Radhika Iyer; Alexandria Jones; Katia Halabi; Matthew Washam; David Sugerman; Mysheika Roberts
PMID: 37535476DOI: https://doi.org/10.15585/mmwr.mm7231a3

---

Access Resources

• Journal ArticleEN
• Ask aRCie About This Resource

About

This report describes a measles outbreak in Central Ohio from October to December 2022. It started with two unvaccinated children and led to 85 confirmed cases, mostly in Franklin County. Many patients were young and had not received the MMR vaccine. The outbreak caused complications like ear infections, diarrhea, and pneumonia, with some requiring hospitalization. Health officials worked to control the spread by quarantining contacts and providing vaccines or immune globulin as post-exposure treatment. The event highlights the importance of timely vaccination to prevent such outbreaks in undervaccinated communities.

---

Tags

Focus Area: Infectious Disease

Audiences: Nurses; Physicians

Emergency Management Stages: Response; Preparedness (Prevention / Protection)

Keywords: Disease Outbreaks; Measles; Measles Vaccine; Ohio; Vaccination Coverage

Institutions: Centers for Disease Control and Prevention (CDC)

---

More like this

Notes from the Field: Reemergence of Mycoplasma pneumoniae Infections in Children and Adolescents After the COVID-19 Pandemic, United States, 2018–2024 2024 · Centers for Disease Control and Prevention (CDC), Maximus Federal Services, Inc., ICF Meeting Summary: State and Local Implementation Strategies for Increasing Access to Contraception During Zika Preparedness and Response — United States, September 2016 2017 · Centers for Disease Control and Prevention (CDC), Association of Schools & Programs of Public Health Cost-Effectiveness of Nirsevimab for Respiratory Syncytial Virus in Infants and Young Children 2024 · University of Michigan, Centers for Disease Control and Prevention (CDC), U.S. Public Health Service

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---